Clerico, Michele
Ferrero, Simone
Alessandria, Beatrice
Zaccaria, Gian Maria
Genuardi, Elisa
Ragaini, Simone
Tavarozzi, Rita
Cavallo, Federica
Hohaus, Stefan
Musuraca, Gerardo
Carella, Angelo Michele
Stelitano, Caterina
Tani, Monica
Gaidano, Gianluca
Olivieri, Jacopo
Usai, Sara Veronica
Galimberti, Sara
Re, Francesca
Mian, Michael
Castellino, Claudia
Pavone, Vincenzo
Evangelista, Andrea
Bruno, Benedetto
Cortelazzo, Sergio
Passera, Roberto
Ladetto, Marco
Article History
Received: 14 February 2024
Accepted: 17 July 2024
First Online: 23 July 2024
Competing interests
: SF: Janssen, Recordati, Abbvie, Gilead, Beigene, Morphosys, Incyte, Clinigen, Italfarmaco, Astra Zeneca, Roche, Sandoz, Servier, Gentili; ML: AbbVie, Acerta, Amgen, GSKI, Gentili, Sandoz, Gilead/Kite, Novartis, Roche, Eusapharma, Takeda, Regeneron, Incyte, and Jazz, ADC Therapeutics, BeiGene, Celgene, Janssen; RT: Lilly, Janssen-Cilag; FC: Roche, Astra Zeneca, Servier; GG: Astra Zeneca, BeiGene, Incyte, Janssen, Lilly, Abbvie, Astra-Zeneca, Hikma, Janssen.